Solaxa Inc.
- | Biotech or pharma, therapeutic R&D
Solaxa is developing treatments for rare neurodegenerative diseases and acute nerve injuries caused by physical trauma and chemotherapy. The company specializes in developing aminopyridines, a potent class of voltage-gated ion channel blockers that restore nerve function.
Address
BethesdaMaryland
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}